Wednesday, August 24, 2016

Adding Annual Screening Tomo To 2D Mammography Starting At Age 40 May Be Cost-Effective, Study Suggests.

HealthImaging (8/23, Pearson) reports, “Adding annual screening tomosynthesis to 2D mammography beginning at age 40 is cost-effective compared with 2D mammography alone,” researchers found. The study, which “incorporated data from a multi-institutional study of more than 450,000 patients, institutional data of 13,000 patients, literature values and Medicare reimbursement rates,” revealed, however, that “net monetary benefits of the extra exam are around three times greater for women in their 40s than for those in their 50s and older.” The findings were published online in the American Journal of Roentgenology. 
Author: wKesha

Categories: 2016, August, News, Policy and Economics, Screening and MammographyNumber of views: 7220


Theme picker